This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Pier Luca Bencini, MD; Carlo Crosti, MD; Francesco Sala, MD; Egidio Bertani, MD; Marco Nobili, MD
Instituto di Clinica Dermatologica Universita di Milano Via Pace 9 20122 Milan, Italy

Arch Dermatol. 1985;121(7):838.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Amiodarone is an iodinated cardiac antiarrhythmic drug, commonly used in Europe, that has some cutaneous side effects. We report herein a case of fatal Lyell's disease associated with amiodarone administration in a patient with cardiac dysrhythmias.

Report of a Case.—

75-year-old man affected by atrial fibrillation and ectopic ventricular contractions was treated with 400 mg/day of amiodarone hydrochloride during his hospitalization in a cardiologic unit. Ten days after receiving amiodarone, marked erythema was seen on the patient's axillae and groin, subsequently spreading over more extended areas, with blister formation at the eyelids, mouth, and perigenital areas. Despite methylprednisolone perfusion (80 mg/day intravenously [IV]) the disease worsened in the following days. For this reason the patient was referred to our clinic.

At the time of dermatologic examination, a generalized bullous eruption was present, with wide and flaccid blisters. Large sheets of the epidermis stripped off, leaving exposed, oozing, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?